These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9383597)

  • 1. Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography.
    Grayburn P
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I12-8. PubMed ID: 9383597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.
    Quay SC; Eisenfeld AJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I19-26. PubMed ID: 9383598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The improvement of echocardiographic assessment of the left ventricle by the use of perflenapent and harmonic imaging].
    Olszewski R; Marciniak W; Nowicki A; Gil M; Etienne J; Karłowicz P; Adamus J
    Pol Merkur Lekarski; 1998 Sep; 5(27):132-4. PubMed ID: 10101477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease.
    Kitzman DW; Wesley DJ
    Am Heart J; 2000 Jun; 139(6):1077-80. PubMed ID: 10827390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group.
    Robbin ML; Eisenfeld AJ
    Radiology; 1998 Jun; 207(3):717-22. PubMed ID: 9609895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing.
    Wellman G; Sherrin T
    Clin Ther; 1997; 19(4):837-46. PubMed ID: 9377626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficiency of Echogen. Transthoracic echocardiography study].
    Espinola-Zavaleta N; Yánac-Chávez P; Vargas-Barrón J; Romero-Cárdenas A; Roldán-Gómez J
    Gac Med Mex; 2001; 137(3):203-8. PubMed ID: 11432089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects.
    Beppu S; Matsuda H; Shishido T; Matsumura M; Miyatake K
    J Am Soc Echocardiogr; 1997; 10(1):11-24. PubMed ID: 9046489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Grayburn PA; Weiss JL; Hack TC; Klodas E; Raichlen JS; Vannan MA; Klein AL; Kitzman DW; Chrysant SG; Cohen JL; Abrahamson D; Foster E; Perez JE; Aurigemma GP; Panza JA; Picard MH; Byrd BF; Segar DS; Jacobson SA; Sahn DJ; DeMaria AN
    J Am Coll Cardiol; 1998 Jul; 32(1):230-6. PubMed ID: 9669275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.
    Hundley WG; Kizilbash AM; Afridi I; Franco F; Peshock RM; Grayburn PA
    J Am Coll Cardiol; 1998 Nov; 32(5):1426-32. PubMed ID: 9809958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of left ventricular perfusion defects using real-time three-dimensional myocardial contrast echocardiography.
    Camarano G; Jones M; Freidlin RZ; Panza JA
    J Am Soc Echocardiogr; 2002 Mar; 15(3):206-13. PubMed ID: 11875382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study.
    Lopez-Ben R; Robbin ML; Weber TM; Smith JK; Needleman L; Berland LL
    J Ultrasound Med; 1999 Feb; 18(2):109-16. PubMed ID: 10206803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.
    Main ML; Escobar JF; Hall SA; Grayburn PA
    J Am Soc Echocardiogr; 1997 Oct; 10(8):798-804. PubMed ID: 9356943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids.
    Correas JM; Quay SD
    Clin Radiol; 1996 Feb; 51 Suppl 1():11-4. PubMed ID: 8605764
    [No Abstract]   [Full Text] [Related]  

  • 18. New ultrasound contrast agents for left ventricular and myocardial opacification.
    Kasprzak JD; Ten Cate FJ
    Herz; 1998 Dec; 23(8):474-82. PubMed ID: 10023581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast echocardiography: current and future applications.
    Mulvagh SL; DeMaria AN; Feinstein SB; Burns PN; Kaul S; Miller JG; Monaghan M; Porter TR; Shaw LJ; Villanueva FS
    J Am Soc Echocardiogr; 2000 Apr; 13(4):331-42. PubMed ID: 10756254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved endocardial border delineation during dobutamine stress echocardiography using the left heart contrast medium BY 963].
    Frieske R; Kühl H; Yuan D; Lepper W; Franke A; Hoffmann R
    Z Kardiol; 2000 Mar; 89(3):186-94. PubMed ID: 10798274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.